Pain Management

The Pharmacy Times® Pain Management resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, among other items that pharmacists will find valuable.

What can we help you find?
[[thumbnail_alt_text]]
To streamline the way opioid treatments are administered and to successfully treat addicts, a pharmacist’s clinical expertise is maximized in a medication-assisted treatment  setting within opioid treatment programs. 
[[thumbnail_alt_text]]
Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, explains key facts pharmacists should know about cannabidiol products and pain management. 
[[thumbnail_alt_text]]
Published in the Journal of the American Medical Association, the study was conducted using a segmented regression analysis of an interrupted time series over a course of 30 months.
[[thumbnail_alt_text]]
Hydromorphone prescription rates may explain the recent increase in cases of infective endocarditis among people who inject drugs.
[[thumbnail_alt_text]]
The action marks the first and only OTC topical drug with cannabidiol to receive certification for its listing in the National Drug Code Directory, according to its manufacturer.
[[thumbnail_alt_text]]
Specialty pharmacists are well positioned to manage the opioid epidemic because they are in regular contact with their patients who trust them.
[[thumbnail_alt_text]]
Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, discusses best uses for opioids, and when to use other pain medications. 
[[thumbnail_alt_text]]
Shared decision making is a tool used by health care professionals to educate more thoroughly, and communicate with their patients.
[[thumbnail_alt_text]]
The statement pointed out that the spread of legalized marijuana products has increased the need for unified labeling requirements.
[[thumbnail_alt_text]]
Expert panelists conclude their discussion with parting advice on the management of opioid-induced constipation.
[[thumbnail_alt_text]]
Turning toward the future management of opioid-induced constipation, the panel defined unmet needs and potential evolutions in care.
[[thumbnail_alt_text]]
Comprehensive insight regarding the cost and timing of peripherally acting mu-opioid receptor antagonist therapy in opioid-induced constipation.